Maker's videoMMI - Medical Microinstruments, Inc. · 8 Oct 2025
Robotic-assisted Lymphovenous Bypass for Breast Cancer Related Lymphedema│ A Symani® Patient Story
Against the record
Symani, from MMI (Medical Microinstruments), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 4 May 2026: Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Nora developed breast cancer-related lymphedema in her left arm following cancer treatment 30 years ago. Now, after being treated for breast cancer a second time, a new robotic surgical solution is available to treat her lymphedema. Dr. Robert Van elected to perform robotic-assisted lymphovenous bypass with Symani to treat Nora's symptoms and reduce her infections. Watch her story to hear about her experience and the benefits of this surgical treatment option. Learn more about the new possibilities in lymphedema care enabled by the Symani Surgical System: https://www.mmimicro.com/clinical-applications/lymphedema/
Written by MMI - Medical Microinstruments, Inc. on YouTube.
More videos of Symani
The Synaptix™ Digital Surgery Platform: Purpose-Built to Enhance Symani®
Symani® Workflow | Robotic-assisted Procedure set-up with the Symani Surgical System
Symani® Surgical System Product Video | Robotic System Overview
MicroChats: Why Robotics in Microsurgery Matters
Robotic-Assisted Breast Reconstruction with Symani | A Connecting the Dots Series Story
Robotic-Assisted Breast Reconstruction Surgery | DIEP Surgery | A Symani® Patient Story